Skip to content
Home/Companies/MedTech/Stille

Stille

MedTech·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Stille?

Stille is currently owned by Impilo through Impilo Investment Pool 2 (2021 vintage), since 2023.

Hand-verified · updated 2026-08-17

Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQSweden
SectorMedTech
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Decon
Active
MedTechSweden· 2023
Pelago Bioscience
Active
PharmaSweden· 2023
VaccinDirekt
Active
HealthcareSweden· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Appasamy
Appasamy
Active
Warburg PincusIndia
Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Genesis MedTech
Genesis MedTech
Active
General AtlanticUS
Medline
Active
The Carlyle GroupUS
Track Stille

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Stille?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Stille.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue